Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Lungs Article
This is a selection made from among articles on Drug Treatment Lungs. For a permanent link to this article, or to bookmark it for future reading, click here.
Getting High... Can You Get Off It?
from: It is often said that each person is unique and totally distinct from the eight billion other people on the planet. Different people have different interests, biases, wants, needs, and desires. Where these interests and desires take a person in life totally depends on each decision that is made every day. For example, a typical teenager in college can choose between being a “do-gooder” whose life revolves around the home and the classroom; or going just a bit wild and experiment with all sorts of new things. Experiencing new things can be as simple as meeting girls, having intimate relationships, to drinking alcohol, or to something as risky as taking drugs.
Teens who experiment with drugs often do so because of peer pressure and the need to belong. Poor choice in friends can lead an otherwise normal teenager to go over board and become addicted to illegal drugs. Sometimes, the pressure and bad influence from peer groups can overcome a teenager's sense of right and wrong, or the values and principles taught to them from the home and the church. Some who do not get hooked on drugs say that they tried doing drugs just to satisfy the curiosity about how it feels to “get high.”
The usual period for a person to experience and try new stuff would be during their teenage years, since their curiosity for the world is at its highest point around that age. Almost all of us have been exposed to drugs and alcohol at some point in our life. Alcohol is considered as a social drink for some, but this could lead to a more difficult alcohol addiction, or alcoholism. A more alarming fact would be to know that a certain number of teenage boys and girls get addicted to drugs, such as marijuana, “crystal meth”, or even LSD. This addiction could lead into a more dangerous position, causing them to go into drug rehabilitation.
Of course, a recovering addict would naturally be anxious or frightened by the prospect of being confined in a drug rehabilitation facility. Anxiety is present and felt at all times since they do not know what to see and think after they get out of rehab. Turning them into rehab may also cause depression, not just for the patient, but for the parents as well. Of course, the addict does not want to be into rehab because of the fact that they cannot use their drug inside the premises and that they will be separated from their drug- addicted friends. This isolation or separation would naturally cause depression. It would be a hard time for both the parents and the patient since this would be a time for detoxification, counseling, and basic addiction treatment.
Being inside a rehabilitation center would be like punishment for the addict. In this scenario, they are required to attend, listen, cooperate, and learn the benefits of having a healthy, drug-free life, instead of being addicted and enslaved by a chemical substance. In case they have to stay there for a set period of time, thoughts of depression and feelings of withdrawal from their drug may arise. These patients may be hard to talk to or communicate with due to their withdrawal symptoms. By having a relaxed and calm environment, this could help in releasing stress and anxiety from the patients, as well as giving them a fresh perspective on life.
Whether the addict is registered in the rehabilitation center as an out-patient, short term in-patient, or long term in-patient programs, they would have to deal with drug counseling activities, open forums, and educational facilities that might help in decreasing their need for drugs. Depression should decrease as time flies because through the rehabilitation sessions, the patient would learn how to be set free from the addiction and get back on the road to recovery.
About Author
Choose Variety of High Quality Medicines at Online MedicinesEnjoyed Reading this article? More here: Pharmacy Articles
Source: ArticleTrader.com
Drug Treatment Lungs Specific links
Drug Treatment Lungs News
First, do no harm: Study finds danger in standard treatment for a serious lung ... - MarketWatch (press release)
First, do no harm: Study finds danger in standard treatment for a serious lung ... MarketWatch (press release) A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to ... |
Danger in standard lung disease treatment - CBS42
Danger in standard lung disease treatment CBS42 Its causes are not clear, making it an "idiopathic" disease, and it is considered "interstitial" because it affects the tissue around the air sacs in the lungs. The standard care to treat IPF consists of a combination of three drugs: Prednisone, ... |
Discovery Expected to Shift Research Direction in Lupus and Asthma - Science Daily (press release)
Discovery Expected to Shift Research Direction in Lupus and Asthma Science Daily (press release) ScienceDaily (May 27, 2012) — Newfound details of the immune system suggest a role for never-before-considered drug classes in the treatment of allergic and autoimmune diseases, according to a University of Alabama at Birmingham study published online ... |
New Drug Combination To Treat Lung Cancer - IBTimes.co.uk
 IBTimes.co.uk | New Drug Combination To Treat Lung Cancer IBTimes.co.uk They claim that the two-drug combination will starve the tumours by simultaneously blocking cancer cell growth. To prove the effectiveness of the drugs, the researchers are planning to conduct two studies on more than 40 lung cancer patients across ... |
MediciNova asthma drug fails trial; shares crash - Reuters
MediciNova asthma drug fails trial; shares crash Reuters MN-221 looks to treat the condition by bypassing constricted airways to deliver the drug directly into the lungs. It aims to improve FEV1 ratio when compared with a placebo. FEV1 ratio measures volume of air exhaled in the first second. |
Vertex Pharma receives European recommendation for approval of cystic fibrosis ... - Proactive Investors USA & Canada
 Proactive Investors USA & Canada | Vertex Pharma receives European recommendation for approval of cystic fibrosis ... Proactive Investors USA & Canada The company said the medicine is the first to treat the underlying cause of the disease. Vertex is a medicinal company focused on discovering, developing, and producing small molecule drugs for the treatment of serious diseases. Vertex finds key support for cystic fibrosis drug in Europe |
Vertex shares soar on cystic fibrosis drug data - Reuters
 Boston Globe | Vertex shares soar on cystic fibrosis drug data Reuters Kalydeco, which in January became the first approved drug to treat the underlying cause rather than symptoms of the life-shortening lung disease, helps only about 4 percent of cystic fibrosis patients with a specific gene mutation. A One-Two Punch Against Cystic Fibrosis, And Maybe Someday Other Diseases Too Vertex Cystic Fibrosis Combo Aids Breathing in Patients Shares of Vertex rise as cystic fibrosis combo improves breathing |
MediciNova asthma drug fails trial; shares crash - Reuters
MediciNova asthma drug fails trial; shares crash Reuters MN-221 looks to treat the condition by bypassing constricted airways to deliver the drug directly into the lungs. It aims to improve FEV1 ratio when compared with a placebo. FEV1 ratio measures volume of air exhaled in the first second. |
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ... - MarketWatch (press release)
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ... MarketWatch (press release) People treated with KALYDECO experienced significant and sustained improvements in lung function, weight gain and certain quality of life measurements compared to those on placebo. In addition, people who took KALYDECO were 55 percent less likely to ... |
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute ... - MarketWatch (press release)
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute ... MarketWatch (press release) ... drugs where they are needed, and may offer new options in asthma therapy that address not only the symptoms, but also the underlying causes of the disease." AsthmaAsthma is recognized as a chronic inflammatory disorder of the lungs and respiratory ... |